Jane Street’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Jane Street’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,639	Closed	-$10.5K	–	10708
2024 Q2	$10.5K	Buy	+11,639	New	+$13.4K	﹤0.01%	9104
2023 Q3	–	Sell	-1,706	Closed	-$6.53K	–	9581
2023 Q2	$6.53K	Buy	+1,706	New	+$6.36K	﹤0.01%	8477
2023 Q1	–	Sell	-5,560	Closed	-$14.9K	–	10175
2022 Q4	$14.9K	Buy	5,560 +2,990	+116%	+$16.5K	﹤0.01%	8672
2022 Q3	$12K	Buy	+2,570	New	+$18K	﹤0.01%	9317
2022 Q2	–	Sell	-1,994	Closed	-$27K	–	11197
2022 Q1	$27K	Buy	+1,994	New	+$34.6K	﹤0.01%	9865

Other funds holding BTCY

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

PWA

Provenance Wealth Advisors Fort Lauderdale, Florida $945M AUM 17.16% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Jane Street's BTCY Position: Q3 2024 in Review

Jane Street sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 11,639 shares — an estimated $10.5K sold.

Jane Street first reported a position in BTCY in Q1 2022 and held it in 5 quarters. The position peaked at $27K in Q1 2022. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

Jane Street reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Jane Street sold 11,639 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $10.5K.
Jane Street first reported a position in Biotricity, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Jane Street's Biotricity, Inc. Common Stock position peaked at $27K in Q1 2022.
5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.